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SUMMARY
Despite substantial self-renewal capability in vivo,
epithelial stem and progenitor cells located in various
tissues expand for a few passages in vitro in feeder-
free condition before they succumb to growth arrest.
Here, we describe the EpiX method, which utilizes
small molecules that inhibit PAK1-ROCK-Myosin II
and TGF-b signaling to achieve over one trillion-fold
expansion of human epithelial stem and progenitor
cells from skin, airway, mammary, and prostate
glands in the absence of feeder cells. Transcriptomic
and epigenomic studies show that this condition
helps epithelial cells to overcome stresses for contin-
uous proliferation. EpiX-expanded basal epithelial
cells differentiate into mature epithelial cells
consistent with their tissue origins. Whole-genome
sequencing reveals that the cells retain remarkable
genome integrity after extensive in vitro expansion
without acquiring tumorigenicity. EpiX technology
provides a solution to exploit the potential of tis-
sue-resident epithelial stem and progenitor cells for
regenerative medicine.
INTRODUCTION
Tissue-resident stem cells ensure homeostasis and tissue repair
throughout the lifetime of an individual. In various epithelia, the
stem and progenitor cells residing in the basal layer are marked
byKRT5and TP63 andhave infinite self-renewal capability in vivo
(Blanpain and Fuchs, 2014; Donati and Watt, 2015; Hogan et al.,
2014; Rock et al., 2010). However, it has been difficult to exten-
sively expand epithelial cells in vitro in feeder-free condition due
to the CDKN2A-dependent stasis (Shay and Wright, 2007).
Immortalization using telomerase reverse transcriptase (TERT)
or viral genes (SV40 T or HPV16 E6/E7) significantly alters epithe-
lial cells behavior, limiting their utility for studying normal biology
or as drug-screening models (Miller and Spence, 2017). Lack of
suitable long-term expansion methods has hampered epithelial
stem cell biology study in vitro and greatly stalled advances in
regenerative medicine exploiting their potential. Pluripotent
stem cells (PSCs), including induced PSCs, have been the
subject of intense research in the hope that they offer physi-
ology-relevant models and solutions for regenerative medicine.
However, they face challenges including donor variability, ac-
quired oncogenic mutations, and inefficient differentiation
toward mature cell types (Avior et al., 2016; Merkle et al., 2017).
Encouraging progress has been made in developing methods
that allow continuous in vitro propagation of epithelial cells. Liu
et al. proposed that feeder cells and Rho-kinase (ROCK) inhibitor
Y-27632 ‘‘conditionally reprogrammed’’ (CR) epithelial cells to
proliferate continuously (Butler et al., 2016; Chapman et al.,
2010; Liu et al., 2012; Suprynowicz et al., 2012). The Stingl group
used a similar approach to expandmammary repopulating units,
an indication of the expansion of mammary epithelial progenitors
(Prater et al., 2014). The CRmethod has garnered interest due to
its successful use in expanding patient-derived epithelial cells to
identify effective therapy (Crystal et al., 2014; Yuan et al., 2012).
Wang et al. (2015) used feeder cells and several small molecules
regulating TGF-b, WNT, and NOTCH pathways to expand
‘‘ground-state intestinal stem cells.’’ However, the use of feeder
cells complicates the interpretation of signaling events that
govern cell proliferation and creates challenges in meeting
regulatory expectation for manufacturing cell therapy products
(Lipsitz et al., 2016).
The Clevers group has led the way in developing feeder-free
3D organoids for intestinal stem cells (Sato et al., 2009, 2011),
which has later expanded to epithelial cells from liver, pancreas,
and stomach (Boj et al., 2015; Huch et al., 2013, 2015). Stem
cells, progenitors, and differentiated epithelial cells are present
in the organoid, making it a good in vitro model for epithelial
cell biology. Katsuda et al. (2017) reported the use of small
molecules, including Y-27632, A83-01, and CHIR99021, which
converted rodent hepatocytes into proliferative bipotent cells;
however, it did not work for human hepatocytes.
To develop medium formulations that address aforemen-
tioned issues, including safety, reproducibility, and scale-up
compatibility, we set off to identify small molecules that support
long-term epithelial cell expansion without feeder cells. We
found that the combination of TGF-b signaling inhibition,
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PAK1-ROCK-Myosin II inhibition, and low extracellular [Ca2+]
were key components that transformed traditional culture me-
dium to enable long-term propagation of epithelial cells from
various tissues. High single-cell cloning efficiency and the ability
to differentiate into tissue-specific mature epithelial cell types
suggested that stem and progenitor cells were preserved during
expansion. Remarkably, the cells retained genome integrity with
no tumorigenicmutations after extensive expansion as assessed
by multiple approaches including whole-genome sequencing.
Gradual changes in DNA methylation landscape were the
by-product of long-term culture and had little impact on overall
gene expression profile.
RESULTS
TGF-b Signaling Inhibition and ROCK Inhibition
Synergistically Support Long-Term Epithelial Cell
Expansion in the Absence of Feeder Cells
As epithelial cells quickly cease proliferation when the feeder
cells or Y-27632 are omitted from the CR method (Liu et al.,
2012), we designed a proliferation assay to pharmacologically
screen a focused collection of small molecules modulating
diverse biological pathways governing stem cell self-renewal
and differentiation (Table S1) to develop feeder-free condition
that supports continuous cell proliferation. Human prostate
epithelial cells (PrECs), bronchial epithelial cells (HBECs), and
foreskin keratinocytes (HFKs) were transduced by lentiviruses
expressing nuclear-localized red fluorescent protein (nRFP) to
facilitate automatic cell count. The lentivirus transduction did
not alter cell proliferation. Late-passage cells were cultured for
7 days in the absence of feeder cells and Y-27632 to screen
small molecules. We found that small molecules that inhibit
TGF-b signaling (A83-01, RepSOX, GW788388, SB431542) or
ROCK (SR3677, Y-27632, Thiazovivin, GSK429286) supported
continuous cell proliferation at micromolar concentrations in
the F medium (Figure 1A). Small molecules that affect the WNT
pathway by inhibiting GSK3 (BIO, CHIR99021, BIO-acetoxime,
endo-IWR1), or inhibit Abl kinase (AP24534), or increase intracel-
lular cAMP level (forskolin), or target the NOTCH pathway
(DAPT), also supported continuous cell proliferation to certain
degrees (Figures 1A and S1). Importantly, we found that TGF-b
signaling inhibitor (0.5–2 mM A83-01) and ROCK inhibitor
(5–10 mMY-27632) synergistically promoted epithelial cell prolif-
eration (Figures 1B and S1). PrECs grew for >28 population dou-
blings (PDs) in the F medium plus A83-01 and Y-27632 (F+Y+A)
(Figure S1), much longer than in the control PrGM. Still, the cells
stopped proliferation after several passages in F+Y+A medium,
which was significantly shorter than in the CR condition (Figures
1C and S1) and suggested that additional optimization could
further improve their expansion.
Low Calcium Concentration Enhances the
Growth-Promotion Effect of TGF-b Signaling Inhibition
and PAK1-ROCK-Myosin II Inhibition
F medium contains 1.4 mM CaCl2, which is known to promote
epithelial cell differentiation (Hennings et al., 1980; Martin et al.,
1991), so we conjectured that low [CaCl2] might further promote
cell growth. We used keratinocyte-SFM (KSFM) that contains
90 mM CaCl2 to pan the small molecules and observed similar
synergy between TGF-b and ROCK inhibitors (Figures 1D, 1E,
and S2). HBECs and PrECs achieved >1,000,000-fold expansion
in KSFM plus A83-01 and Y-27632 (K+A+Y) versus control (Fig-
ure S2). This confirmed that neither TGF-b nor ROCK inhibition
alone supports extended epithelial cell proliferation (Chapman
et al., 2014; Natarajan et al., 2006). In KSFM, TGF-b inhibition
had the biggest impact on cell growth, while in the F medium
ROCK inhibition was the primary hit (Figures 1D and 1E). Inter-
estingly, elevating the [Ca2+] in KSFM reduced the growth-
promoting effect of A83-01 but boosted the effect of Y-27632
(Figure S3). Additionally, we found that IPA-3 (inhibitor for
PAK1) or blebbistatin (inhibitor for Myosin II) synergistically pro-
moted cell proliferation with A83-01 (Figures 1D and S2). HBECs,
keratinocytes (neonatal and adult), and PrECs expanded
for >1,000,000-fold in KSFM plus A83-01 and IPA-3 or blebbis-
tatin over KSFM control (Figure S2). These findings suggested
that, in the absence of feeder cells, inhibiting PAK1-ROCK-
Myosin II axis promoted epithelial cell proliferation in low-cal-
cium medium when the TGF-b signaling was also suppressed.
We sieved the small molecules with the K+A+Y medium and
found some agents that further promoted cell proliferation,
including IBMX, 8-bromo-cAMP, prostaglandin E2, and DPPIV
inhibitor (Figure S2). Notably, the synergy between A83-01 and
Y-27632 was independent of KSFM, as they also supported
long-term epithelial cell expansion in BEGM (Lonza), Bronchia-
Life (Lifeline), or LHC-9 (GIBCO) (data not shown). We used
KSFM plus 1 mM A83-01, 5 mMY-27632, and 3 mM isoproterenol
and dubbed it epithelial expansion medium (EpiX). Panning
the small molecules using the EpiX medium did not reveal any
significant hits.
We have established epithelial cell cultures from neonatal fore-
skin, adult skin, nasal, bronchial, prostate, mammary, and other
tissues using the EpiX medium and propagated them for 40–90
PDs (Figures 1I–1L and S4), far beyond the 15–25 PDs obtained
in conventional media. We routinely generated >50 million
epithelial cells from nasal brushing samples in 3–4 weeks (Fig-
ure S4). EpiX medium supported multi-round single-cell cloning
with high efficiency, suggesting that epithelial stem and pro-
genitor cells were preserved during the clonal expansion. This
allowed us to knock the GFP gene into the AAVS1 locus in
HFKs using CRISPR/Cas9 for clonal expansion (Figure S5).
Transcriptome Dynamics of Epithelial Cells Expanded in
the EpiX Medium
We examined HFKs and HBECs cultured in the EpiX medium by
qRT-PCR and found the cells maintained steady expression of
basal cell markers (ITGA6, ITGB4, KRT14, KRT5, TP63; Table
S2). Immunofluorescence staining demonstrated that all cells
strongly expressed TP63 (Figure 1H). PSC markers (LIN28A,
NANOG, OCT4) and other stem cell markers (CD34, AXIN2,
LGR5, PROM1) were not activated, indicating that EpiX did not
reprogram the cell identity (Table S2). Markers of differentiated
cells (IVL, LOR, MUC5AC, SFTPB, SGCB1A1, FOXJ1) were ab-
sent in the proliferating cells. Interestingly, qRT-PCR assay de-
tected weak expression of TERT in PrECs and HBECs cultured
in EpiX similar to that in the CR method (Figure S6). Genes
involved in stress responses and senescence (AKT1, ATM,
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CDKN2A, GADD45A, GLB1, PLAU, SERPINE1) expressed
at much lower levels in cells cultured in the EpiX than in KSFM
(Figure S6), suggesting that the EpiX medium alleviated various
stresses.
To assess the global impact of EpiX medium on gene expres-
sion, we compared a total of 14 HFK transcriptomes under
various conditions by RNA sequencing (RNA-seq) (Figure 2A;
Table S3), which recapitulated the sustained expression of basal
Figure 1. TGF-b Signaling Inhibition, ROCK Inhibition, and Low Calcium Synergistically Support Long-Term Epithelial Cell Proliferation
(A) Small molecules inhibiting the TGF-b signaling or ROCK supported the proliferation of late-passage PrECs/nRFP cells in the absence of feeder cells in
the F medium. Data are represented as mean ±SD, n = 4.
(B) Synergy between A83-01 and Y-27632 in the F medium (four replicates per condition).
(C and F) PrECs/nRFP cells proliferated for 10 PDs in the F medium plus Y-27632 and A83-01 (F+Y+A) but continued to proliferate in the CR condition (C). Many
cells in F+Y+A exhibited differentiated morphology (F).
(D) ROCK inhibitors synergistically promoted the proliferation of HBECs/nRFP cells in KSFM plus 1 mM A83-01.
(E) Synergy between A83-01 and Y-27632 in KSFM (four replicates per condition).
(G) Morphology of HFKs over successive passages in KSFM (P1 and P5) or the EpiX medium (P2, P11, and P20).
(H) TP63 was ubiquitously expressed in late-passage HFKs (P16) cultured in the EpiX medium.
(I–L) Expansion of HFKs (I), PrECs (J), HBECs (K), and mammary epithelial cells (L) in KSFM or EpiX.
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Figure 2. Transcriptome Analysis of HFKs Expanded with the EpiX Medium
(A) Experimental scheme of HFK expansion in KSFM or the EpiX medium and time points for samples collection. HFKs underwent three different routes: (1) stasis
in KSFM (P2/P5); (2) transient exposure and withdrawal from the EpiX medium (P2/P3/P4); and (3) expansion in the EpiX medium and withdrawal at late
passage (P3/P12/P19/P20). Each sample was collected in duplicate.
(B) PCA on HFK transcriptomes in various conditions. The red arrows represented the direction of culture condition changes.
(C) MA plot of differentially expressed genes in two different media. The red dots represented differentially expressed genes.
(D) Temporal expression changes of two top downregulated genes, VIM (solid line) and FN1 (dashed line).
(E) Heatmap of 962 downregulated genes in HFKs expanded with the EpiX medium. These downregulated genes were de-repressed when the HFKs were
withdrawn from EpiX medium. The red arrows indicated EpiX medium withdrawal.
(F) Gene ontology (GO) and pathway enrichment analysis of upregulated and downregulated genes by metascape tool.
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cell markers and absence of PSCs and terminal differentiation
markers (Figure S6; Table S2). Globally, two transcriptomic shift
trends were illustrated by principal-component analysis (PCA)
(Figure 2B), with a major shift associated with media change
and aminor shift associatedwith long-term culture.We identified
1,277 differentially expressed genes in HFKs expanded in EpiX
versus in KSFM, comprising 315 upregulated and 962 downre-
gulated genes (Figure 2C; Table S3). Downregulated genes
were enriched in cell-cell interaction, interferon signaling, extra-
cellular matrix organization, and cytokine signaling (Figure 2F).
As expected, we observed significant downregulation of
genes involved in senescence (PLAU, SERPINE1, VIM) and the
TGF-b pathway (FN1, SKIL, ITGB6) (Figures 2C, 2D, and S6).
Importantly, the downregulated genes were de-repressed
when HFKs were withdrawn from the EpiX medium (Figure 2E),
suggesting that repression of these genes in EpiX was not a
permanent but reversible process.
Epithelial Cells Expanded with EpiX Medium Retain
Remarkable Genome Stability
Epithelial cells generally encounter stasis around passage 5–6
in conventional media (Shay and Wright, 2005, 2007), while a
few cells may acquire spontaneous suppression of CDKN2A
to evade stasis and eventually result in chromosome abnormal-
ity and oncogenic mutations (Romanov et al., 2001). We exam-
ined HFKs, HBECs, and PrECs cultured for over 40 PDs in
the EpiX medium and found they all retained normal diploids
(Figure 3A). Whole-genome sequencing (WGS) of HBECs
from a cystic fibrosis patient (CF) and HFKs only found 5,083
de novo single-nucleotide variations (SNVs) in the CF sample
after 43 PDs, and 4,800 de novo SNVs in the HFK sample
after 42 PDs (Figure 3D; Table S4). Average SNV rate was
1.97 3 108/bp/generation in the CF and 1.90 3 108/bp/
generation in the HFKs, close to the 1.5 3 108/bp/generation
rate observed in germline cells (Rahbari et al., 2016). Less than
0.4% (39/9,844) of those SNVs were common between the CF
and HFK samples and they all located in non-coding areas and
none had known detrimental effects (Figure 3D; Table S4). Over
99.2% of the 9,844 SNVs located outside coding regions, and
the remaining (25 in CF and 24 in HFK) led to heterozygous
missense variants (Table S4). We did not detect any mutation
in oncogenes (e.g., MYC, RAS) or tumor suppressor genes
(e.g., TP53, RB), suggesting that the EpiX medium neither
induced nor favored oncogenic mutations. Whole genome-
sequencing revealed 60 small insertions and deletions (InDel)
in the CF sample and 26 InDel in the HFK sample, all located
in introns or intergenic regions (Table S4). Twenty-four copy
number variations (CNVs) affecting 1.7 Mb (CF) and one
86-kb CNV (HFK) all located in repeat elements (Table S4;
Figure S7). We found one structural variation (SV) in the CF
sample and two in the HFK sample (Table S4). None of these
CNVs or SVs are functionally linked to tumors. We injected
1 3 107 young HFKs (<20 PDs) differentiated in a high-calcium
medium for 7 days (see below), old HFKs (>50 PDs) differenti-
ated for 7 days, or old HFKs (>50 PDs) in active proliferation
subcutaneously into nude mice, and found no tumors after
12 weeks (Figure 3B), indicating that EpiX-expanded epithelial
cells were not tumorigenic.
Tissue-Restricted Differentiation of Epithelial Cells
after Long-Term Expansion in EpiX Medium
Increasing [Ca2+] above 1 mM in the EpiX medium quickly led
to the formation of tight junctions stained positive for ZO-1 and
Occludin (Figures 4A and 4B). Mini-domes occurred sporadically
in confluent HFKs or HBECs cultured in EpiX with 1 mM CaCl2
(Figures 4C and 4D). An intact epithelium sheet could be
released by Dispase to create cultured epidermal grafts (Green,
2008) (Figure 4E). HFKs cultured at the air-liquid interface (ALI)
matured into stratified epithelium after 2 weeks (Figure 4F). As
expected (Doran et al., 1980), EpiX-expanded HFKs injected
subcutaneously into immunodeficient mice formed epidermis-
like cystic epithelium after 5 weeks, with basal cell layer stained
positive for KRT14 and Ki67 (Figures 4H and 4I), spinous cell
layers, a granular cell layer with evident keratohyaline granules,
and several cornified layers (Figure 4G). Bioluminescence imag-
ing (the HFKs were engineered to express firefly luciferase)
confirmed the presence of HFKs 4 months after engraftment
in the mice, indicating that EpiX-expanded HFKs retained self-
renewal capability in vivo (Figure S8).
HBECs cultured in standard BEGM lose the ability to differen-
tiate into mucociliary epithelium after four to five passages (Neu-
berger et al., 2011). HBECs from several healthy and CF donors
grew for 45–60 PDs (12–16 passages) in the EpiX medium (Fig-
ure 5A), and readily differentiated into mucociliary epithelium at
ALI or bronchospheres in Matrigel. Cilia of the multiciliated cells
spontaneously beat (Videos S1 and S2) and stained positive for
acetylated tubulin, and mucin-producing goblet cells stained
positive by alcian blue or an anti-MUC5AC antibody (Figures 5C
and 5D). High expression of differentiated cell markers (FOXJ1A,
MUC5AC, SCGB1A1) was revealed by qRT-PCR (Figure 5B). The
mucociliary epithelium also maintained physiological functions,
showing a significant increase in MUC5AC+ goblet cells upon
IL-13 stimulation (Figures 5D). Additionally, ion channel physi-
ology expected for their CFTR genotypes was maintained after
>30 PDs (Figure 5E). For HBECs from a healthy donor, CFTR ac-
tivitywas readily stimulatedby10mMforskolin, anddiminishedby
the inhibitor CFTRinh-172. For CF cells with a rare CFTR variant
(DF508:Q685TfsX4), the CFTR corrector (3 mM VX-809) with the
potentiator (100 nM VX-770) increased transepithelial Cl trans-
port (Figure 5E). Amiloride-sensitive epithelial sodium channel
and calcium-dependent chloride channel activities were also
observed. Importantly, the response of CF cells to CFTRmodula-
tors did not decline in late-passage cells (Figure 5E).
Telomere Length and DNA Methylation Landscape
Gradually Change over Long-Term In Vitro Expansion
As shown in Figure 1G, early-passage epithelial cells in the EpiX
medium were small with a high nuclear/cytoplasm ratio and
bright under microscope. The population doubled in <24 hr (Fig-
ures 1I–1L). Large cells accumulated slowly over passages and
eventually the majority of the population appeared senescent
or differentiated. Comparing the transcriptomes of early- versus
late-passage HFKs revealed that many genes involved in the
senescence-associated secretory phenotype (Coppe´ et al.,
2010), including IL6, IL8, IGFBP3, IGFBP5, THBS1, SERPINE1,
and TGFB1l1 increased significantly in late passage (Figure S9).
We examined the telomeres length of EpiX-expanded HFKs by a
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qPCR method (Cawthon, 2002) and observed an inverse corre-
lation between the T/S ratio and the PDs (Figure 6A). Interest-
ingly, HFKs expanded by the CRmethod also exhibited telomere
erosion at a similar rate (Liu et al., 2012), suggesting that the
erosion of telomeres contributed to ultimate growth arrest in
both conditions.
We integrated methylated DNA immunoprecipitation
sequencing (MeDIP-seq) and methylation-sensitive restriction
enzyme sequencing (MRE-seq) (Li et al., 2015; Maunakea
et al., 2010) methods to further examine genome-wide DNA
methylation (DNAme) changes in the HFK samples that were
used in the RNA-seq study (Figure 2A; Table S5). Average DNA
Figure 3. Genome Stability of Epithelial Cells Expanded with the EpiX Medium
(A) HFKs, HBECs, and PrECs expanded with the EpiX medium over 40 PDs retained diploid karyotypes.
(B) EpiX-expanded HFKs did not form tumors after 12 weeks in female nude mice (13 107 cells per mouse, n = 6 in each group). Data are represented as mean
±SD, n = 6.
(C) Data analysis workflow for whole-genome sequencing.
(D) Distributions of de novo SNVs identified by whole genome-sequencing in late-passage HFK and CF samples. Venn diagram showed the overlap between the
CF and HFK samples.
(E) Genes that were affected bymissense de novoSNV (all heterozygous) after 40 PDs expansion in the EpiXmedium. Two separatemissense SNVswere found in
the DDX11 gene in the CF and HFK samples.
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methylation levels in each passage were around 70%–75% with
a slight decrease at higher passages (Figure S10), consistent
with previous reports (Wilson and Jones, 1983). Bimodal distri-
bution revealed a lower number of highly methylated CpGs in
late passages, yet the global DNAmethylation over genic regions
was stable across passages (Figure S10). In contrast to the tran-
scriptomic shifts, PCA showed that passage number was the
only factor that drove DNA methylation change (Figure 6C).
Over 2,400 differentially methylated regions (DMRs) (1,940
DNA methylation gain and 479 DNA methylation loss) were
identified along with the increase in passages, with no statisti-
cally significant DMRs identified between adjacent passages in
different media (Figures 6B and S10). Interestingly, mid-passage
(P12) HFKs exhibited intermediate DNA methylation levels in
these DMRs, confirming the DNA methylation change was
gradual across passages (Figures 6D and S10). The DNAmethyl-
ation changes were maintained after withdrawal of EpiX medium
(Figure S10), suggesting that these changes were driven mainly
by the passage number but not media change.
We next investigated the potential impact of DNA methylation
changes on gene expression. Taking advantage of the Human
Reference Epigenome Map (Kundaje et al., 2015; Lowdon
et al., 2014), we annotated the DMRs using histone modification
data from reference foreskin keratinocytes (E057 and E058) and
found that DMRs occurred more often than expected in pro-
moters or enhancers (Figures 6E and S10; Table S5). The DNA
Figure 4. Differentiation of HFKs Expanded with the EpiX Medium
(A) Addition of 1 mM CaCl2 to the EpiX medium induced the HFKs to differentiate in 24 hr.
(B) Immunofluorescence staining of tight junctions (ZO-1 and Occludin) in HFKs cultured in EpiX plus 1 mM CaCl2 for 7 days. ZO-1, zonula occludens-1.
(C and D) Confluent HFKs in EpiX (C) or EpiX plus 1 mM CaCl2 (D). Many domes with liquid accumulated underneath occurred in the culture with EpiX plus
1 mM CaCl2.
(E) HFKs cultured in a T-75 flask in EpiX plus 1.5 mMCaCl2 for 7 days form an intact epithelium sheet, which was released from the flask after 30-min incubation in
dispase at 37C.
(F) HFKs were differentiated at ALI for 14 days and formed a stratified epithelium.
(G) EpiX-expanded HFKs were subcutaneously injected into immune-comprised mice. After 5 weeks, the cells formed cysts which resembled epidermis.
(H) Most cells in the basal layer were stained positive for the proliferation marker Ki67.
(I) The basal and supra-basal layers of the cystic epithelium stained positive for KRT14 (K14).
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Figure 5. Differentiation of HBECs Expanded with the EpiX Medium
(A) HBECs from healthy and CF donors (n = 4) were expanded in the EpiX medium or conventional medium (BEGM). EpiX medium supported million-fold more
expansion than BEGM (n = 2).
(B) HBECs from a healthy (UNC42I) or a CF donor were expanded in the EpiX medium for 30 PDs and differentiated at ALI for 21 days. The expression of basal cell
markers (TP63, NGFR), multiciliated cell markers (CFTR, FOXJ1A), goblet cell marker (MUC5AC), club cell marker (CC10), or type II cell marker (SFTPD) were
checked by qRT-PCR. Gene expression levels were depicted as relative to that of b-actin, which was set at 1. Data are represented as mean ± SD, n = 3.
(C) UNC42I cells (P8) were differentiated at ALI for 21 days. Paraffin sections were stained with H&E, or with an anti-acetylated tubulin antibody, or with alcian blue
to show multiciliated cells and goblet cells.
(legend continued on next page)
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methylation changes were weakly associated with gene expres-
sion change, and no significant DNA methylation change was
found in or around genes involved in important signaling path-
ways (TGF-b, WNT) and cell cycle (Figure S10). Of all genes
that exhibited promoter DNAmethylation change, 18/126 down-
regulated genes and 0/6 upregulated genes showed expected
gene expression changes (Figures 6F and S10; Table S6). The
majority (112/132, 85%) of genes with promoter DNA methyl-
ation changes remained at low expression levels (transcripts
per million [TPM] < 10; Figure S10), matching previous report
that DNA methylation changes accumulate predominantly at
inactive gene promoters in long-term human cell cultures (Gor-
don et al., 2014). We used a model derived from long-term fibro-
blast culture (Koch et al., 2012) to predict the cumulative PDs
(pcPDs) of the HFKs using DNA methylation levels at certain
CpGs, and found a good correlation between the predicted
and actual PDs (Figure 6G; Table S7). Overall, this suggested
that the majority of DNA methylation changes accompanied
with EpiX expansion were by-products of long-term culture
and not responsible for gene expression changes.
DISCUSSION
As cell behaviors are influenced by diverse external signals, we
postulated that screening small molecules could yield hits if we
focused on desired outcome (e.g., continuous cell proliferation)
even without a priori knowledge on the native stimuli. Through
this approach, we found that TGF-b signaling inhibition and
ROCK inhibition synergistically supported epithelial cell prolifer-
ation in the absence of feeder cells. TGF-b is a well-known cyto-
static factor (Siegel and Massague´, 2003), presumably through
the activation of p21Cip1 and p15INK4b (Bhowmick et al., 2003;
Denicourt and Dowdy, 2003). Noteworthily, Rheinwald proposed
that feeder cells protected epithelial cells from TGF-b growth
inhibition by efficiently degraded TGF-b (Rollins et al., 1989).
Attenuation of TGF-b signaling suppresses premature senes-
cence in a p21Cip1-dependent manner (Lin et al., 2012) or antag-
onizes ATM-mediated growth-arrest response to genotoxic
stress (Kirshner et al., 2006), and TGF-b inhibition rescues he-
matopoietic stem cell defect (Zhang et al., 2016). Nevertheless,
inhibiting TGF-b signaling with small molecule alone cannot
immortalize epithelial cells, but can assist TERT in doing so
(Natarajan et al., 2006).
Modest expressions of TGF-b were detected in epithelial cells
cultured in KSFM by ELISA and RNA-seq (Figures S3 and S6),
suggesting that autocrine TGF-b might contribute to cell growth
arrest. Although RNA-seq detected little change in TGF-b genes
transcription in EpiX versus KSFM (Figure S6), ELISA showed
that A83-01 and Y-27632 together significantly reduced active
TGF-b protein produced by the epithelial cells, although either
had little effect when used alone (Figure S3). The suppression
on TGF-b protein may help explain the synergy between A83-
01 and Y-27632 on promoting cell proliferation, but how the
TGF-b protein is reduced in the absence of transcriptional
changes warrants further investigation.
Recently, the Rajagopal group reported that ‘‘dual SMAD’’
inhibition enables long-term expansion of epithelial basal cells
from airway, skin, and epididymis (Mou et al., 2016), while
they also used Y-27632 and CHIR99021. They concluded that
both TGF-b and BMP pathways needed to be suppressed by
A83-01 and DMH-1, respectively. DMH-1 was included in our
small-molecule collection but did not have a significant impact
on its own nor with either TGF-b or ROCK inhibitors, suggesting
that BMP pathway inhibition may not be critical at least under
in vitro condition.
ROCKs influence a wide variety of signal pathways in eu-
karyotic cells and play pivotal roles in regulating actin cytoskel-
eton, cell polarity, microtubule dynamics, membrane transport
pathways, and transcription factors activities (Etienne-Manne-
ville and Hall, 2002). ROCK inhibitor has been widely used in
mammalian cell cultures presumably for its ability to suppress
anoikis (Watanabe et al., 2007). What has not been highlighted
before is the synergy between TGF-b signaling inhibition and
ROCK inhibition in promoting epithelial cell proliferation as
we delineated in this study. We also found that PAK1 inhibitor
(IPA-3) or Myosin II inhibitor (blebbistatin) had similar synergis-
tic effect on promoting epithelial cell proliferation when used
with A83-01. The Watt laboratory proposed that Hippo effector
YAP nuclear translocation and its co-factor WBP2 as essential
mediator to promote cell proliferation and drive clonal expan-
sion when cytoskeleton and microtubule dynamics are phar-
macologically modulated through the PAK1-ROCK-Myosin II
axis (Walko et al., 2017). We found that Y-27632 but not
A83-01 led to significant cytoskeleton reorganization and
YAP nuclear translocation in HFKs cultured in KSFM with
1.5 mM CaCl2 (Figure S3), which provided an explanation for
ROCK inhibitor as the primary hit in high-calcium F medium
(Figures 1 and S1).
High extracellular [Ca2+] induces epithelial cell differentiation
through promoting intercellular interaction (Martin et al., 1991).
When [Ca2+] is below 0.3 mM, NOTCH-1 is constitutively active
and allows cell-autonomous signaling in the absence of recip-
rocal cell-cell interaction (Dalrymple et al., 2005; Rand et al.,
2000). Interestingly, the low [Ca2+] in KSFM resulted in cytoskel-
etal re-organization and YAP nuclear translocation similar to
adding Y-27632 in the presence of high [Ca2+] (Figure S3). Extra-
cellular Ca2+ also gates cadherin-cadherin homotypic interaction
and influences b-catenin nuclear trafficking and WNT target
genes expression (Nusse and Clevers, 2017). Such miscella-
neous effects of low extracellular [Ca2+] probably overshadow
any activity imparted by the GSK3 inhibitor CHIR99021, which
showed little effect in the EpiX medium.
(D) UNC42I cells (P7) were differentiated at ALI and treated with 1 ng/mL IL-13. Multiciliated cells and goblet cells were stained with anti-acetylated tubulin
(in green) or anti-MUC5AC (in red) antibodies respectively. IL-13 led to goblet cell hyperplasia and a decrease of multiciliated cells.
(E) Early- (15 PDs) and late-passage (30 PDs) CF cells were differentiated at ALI for Ussing assays, using either the Vertex or the PneumaCult-ALI protocol. The
activities of ENaC (DAmiloride, 30 mM amiloride), CFTR (DFsk peak, 10 mM forskolin; DVX-770 peak and DVX-770 plateau, 100 nM VX-770 and 3 mMVX-809) and
CaCC (DUTP, 100 mM UTP) were measured. VX-809, a CFTR trafficking corrector; VX-770, a CFTR potentiator. The responses of mutant CFTR variants to the
CFTR corrector (3 mM VX-809) and CFTR potentiator (100 nM VX-770) were similar between early and late passages. Data are represented as mean ± SD, n = 3.
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Figure 6. Epigenetic Changes in HFKs Expanded with the EpiX Medium
(A) Telomere length (T/S ratio) gradually decreased in HFKs expanded in the EpiX medium or the CR method. Data are represented as mean ±SD, n = 3.
(B) The number of differentially methylated regions (DMRs) identified between different culture conditions. The numbers in upper right cells were DMRs with DNA
methylation gain, and the numbers in lower left cells were DMRs with DNA methylation loss.
(C) PCA of DNAmethylomes. DNAmethylation levels of DMRswere used as input data. The first principal component (passage) explainedmost variances among
the DNA methylomes.
(D) DNA methylation levels in HFKs gradually changed over successive passages in the EpiX medium. The methylation levels of DMRs at P12 was intermediate
between P3 and P19. Also see Figure S10.
(E) The chromatin states of DMRs using 18 chromHMM expanded states in keratinocytes. Lots of DMRs were in regulatory regions such as promoters and
enhancers. Also see Figure S10.
(F) Expression changes of genes whose promoters underwent DNA methylation changes. Expression changes were calculated as log2 of fold change between
P3 and P19. The red dots indicated the genes whose expression was downregulated as expected from the gain of promoter methylation.
(G) Predicted cumulative population doublings (pcPDs) of HFKs based on the DNA methylation levels at six CpG sites correlated with the actual PDs at different
passages.
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Importantly, our study revealed that EpiX-expanded epithelial
cells maintained remarkable genome integrity. The cells retained
normal diploid and had extremely low SNV rate comparable to
germline cells (Rahbari et al., 2016). Nomutations occur in onco-
genes or tumor suppressor genes. On the contrary, many PSC
lines are reported to acquire genomic variations including TP53
mutations with successive passages (Merkle et al., 2017). Cur-
rent PSC differentiation protocols produce epithelial progenitors
that only propagate for a few passages in convention medium
(Firth et al., 2014; Umegaki-Arao et al., 2014). It is tempting to
use EpiX medium to expand PSC-derived epithelial progenitors,
which could reduce the production cost and assure the genomic
quality of end cell products.
Transcriptomic study of HFKs cultured in EpiX versus KSFM
revealed significant downregulation of genes involved in senes-
cence, cell-cell interaction, interferon signaling, extracellular
matrix organization, and stress responses, together with upregu-
lation of genes involved in various metabolic processes and cell
cycle (Figure 2F). Importantly, the impact was not permanent
and reversed upon the withdrawal of EpiX medium (Figure 2E),
allowing the cells to differentiate along their tissue lineages.
Genome-wide DNA methylation study revealed gradual accu-
mulation of DMRs that were mainly associated with successive
passages. These DMRs were weakly associated with gene
expression change, and occurred mostly in the promoters or en-
hancers of low-expression genes, confirming similar observation
in long-term culture of human cell lines (Gordon et al., 2014). The
DNA methylation changes were maintained after withdrawal of
EpiX medium (Figure S10), suggesting that these DMRs were
mainly driven by long-term in vitro expansion.
Cell proliferation eventually ground to a halt in the EpiX me-
dium, presumably due to telomeres erosion that lead to ATM/
TP53-dependent DNA-damage response (Lazzerini-Denchi and
Sfeir, 2016). Conversely, this might be a major contributor of
the remarkable genome integrity due to prompt elimination of
the cells with DNA damages via apoptosis. The accumulation
of senescent cells in late-passage population is an important
quality concern for ex vivo cell manufacturing, as theymay impair
healthy cells’ functions via destructive paracrine effect (Campisi,
2005; Rodier et al., 2009). Recent advances in the identification of
senolytics that can postpone senescence or eliminate senescent
fibroblasts, such as rapamycin (Iglesias-Bartolome et al., 2012),
IL-1Ra (Uekawa et al., 2004), ABT-263 (Chang et al., 2016), and
FOXO4-DRI (Baar et al., 2017), might be useful to further extend
the expansion of epithelial cells.
In summary, the EpiX medium supports over one trillion-fold
expansion of epithelial cells from diverse tissues in the absence
of feeder cells. The EpiX technology provides unique solutions to
unleash the potential of tissue-resident epithelial stem and pro-
genitor cells for cell therapy and regenerative medicine.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal anti-MUC5AC Santa Cruz Biotechnology Cat# sc-20118; RRID: AB_2146854
Mouse monoclonal anti-Acetylated Tubulin Sigma-Aldrich Cat# T7451; RRID: AB_609894
Rabbit polyclonal anti-Ki67 Abcam Cat# ab15580; RRID: AB_443209
Mouse monoclonal anti-KRT14 Thermo Fisher Scientific Cat# MA5-11599; RRID: AB_10982092
Rabbit monoclonal anti-YAP Cell Signaling Technology Cat# 14074; RRID: AB_2650491
Alexa Fluor 594 Phalloidin Thermo Fisher Scientific Cat# A12381; RRID: AB_2315633
Rabbit monoclonal anti-P63 Cell Signaling Technology Cat# 13109; RRID: AB_2637091
ZO-1 Monoclonal Antibody (ZO1-1A12), Alexa Fluor 488 Thermo Fisher Scientific Cat# 339188; RRID: AB_2532187
Occludin Monoclonal Antibody (OC-3F10), FITC Thermo Fisher Scientific Cat# 33-1511; RRID: AB_2533102
Bacterial and Virus Strains
NucLight Red Lentivirus (EF-1 Alpha Promoter, Puromycin
selection)
Essen Biosciences Cat# 4476
Biological Samples
Human foreskin tissue, fresh Zenbio Cat# T-FS
Human nasal brushing samples from CF patients UNC CF Clinics N/A
Chemicals, Peptides, and Recombinant Proteins
Tocriscreen Stem Cell Toolbox Tocris Cat# 5060
A83-01 Sigma-Aldrich Cat# SML0788
Y-27632 dihydrochloride Enzo Life Sciences Cat# ALX-270-333
Isoprenaline hydrochloride Sigma-Aldrich Cat# I5627-5G
(-)-Blebbistatin Selleck Chemicals Cat# S7099
IPA-3 Tocris Cat# 3622
GSK-429286 Sigma-Aldrich Cat# SML0231
Critical Commercial Assays
Telomere length measurements by quantitative PCR service Risques Lab at University
of Washington
http://depts.washington.edu/risques/
G-Band Karyotyping service Cell Line Genetics N/A
Whole genome sequencing service Novogene N/A
Ussing assays service ChanTest, a subsidiary of
Charles River Laboratories
N/A
Histology service (Paraffin section, H&E and alcian blue staining) VitroVivo Biotech LLC N/A
TGF-b ELISA service University of Maryland
Cytokine Core Lab
N/A
RT2 Profiler PCR Array Human Cellular Senescence QIAGEN Cat# PAHS-050ZA-6
In vivo tumorigenicity service Noble Life Sciences N/A
Deposited Data
Raw and analyzed RNA-seq, MeDIP-seq and MRE-seq data This paper GSE103759 containing the Subseries
GSE103756 (RNA-seq), GSE103757
(MeDIP-seq) and GSE103758 (MRE-seq)
Analyzed whole genome sequencing data This paper Figure 3; Table S4
Experimental Models: Cell Lines
Human bronchial epithelial cells, P1, from healthy and CF donors UNC CF Center Tissue
Procurement and Cell
Culture Core
N/A
NHBE-Bronchial Epi Cells for B-ALI Lonza Cat# CC-2540S
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact,
Chengkang Zhang (ck.zhang@propagenix.com)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Primary epithelial cells were purchased from Lonza or ThermoFisher or obtained from academic tissue bank (UNC CF Center). Fresh
human foreskin tissue was purchased from Zenbio for keratinocyte isolation. Fresh human nasal brushing samples were collected
fromCFpatients at UNCCFClinic following approved IRBprotocol. The epithelial cells were cultured in theCR condition, commercial
media (Lonza BEGM, Lonza PrGM, Lonza MEGM, GIBCO KSFM), or the EpiX medium. The EpiX medium was KSFM supplemented
with 1 mMA83-01, 5 mMY-27632 and 3 mM isoproterenol. The epithelial cells were cultured in collagen-coated vessels (Corning) until
they reach 80%–90% confluence, when they were passaged with Trypsin-EDTA and re-seeded into new vessels.
For in vivo animal studies, female nude mice (6-8 weeks old) were used and each group had 6 animals. Body weight and tumor
measurements were recorded twice weekly for 12 weeks. The study was conducted in compliance with the IACUC protocols
established at Noble Life Sciences.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
CF-DHBE - Diseased Bronchial Epi. Cells (CF) Lonza Cat# 196979
Human Epidermal Keratinocytes, adult (HEKa) Thermo Fisher Scientific Cat# C0055C
Human Epidermal Keratinocytes, neonatal (HEKn) Thermo Fisher Scientific Cat# C0015C
HMEC–Human Mammary Epithelial Cells Lonza Cat# CC-2551
LNCap Clone FGC Cell Line human Sigma-Aldrich Cat# D-073-1ML
Human normal prostate epithelial cells Georgetown University N/A
Experimental Models: Organisms/Strains
Nude mice (Noble Life Sciences) Jackson Lab N/A
NSG mice (Noble Life Sciences) Jackson Lab N/A
Oligonucleotides
qRT-PCR primers for TERT (forward primer,
50-TGACACCTCACCTCACCCAC-30, reverse primer,
50-CACTGTCTTCCGCAAGTTCAC-30 and Taqman
probe (50-ACCCTGGTCCGAGGTGTCCCTGAG-30)
This paper N/A
Software and Algorithms
STAR, v.2.5.3a Dobin et al., 2013 https://github.com/alexdobin/STAR
featureCounts (Subread v.1.5.3) Liao et al., 2014 http://bioinf.wehi.edu.au/featureCounts/
DESeq2 bioconductor package v.1.14.1 Love et al., 2014 https://bioconductor.org/packages/
release/bioc/html/DESeq2.html
Metascape Tripathi et al., 2015 http://metascape.org
BWA-MEM v.0.7.10 Li, 2013 http://bio-bwa.sourceforge.net/
methylQA Li et al., 2015 http://methylqa.sourceforge.net/
methylCRF Stevens et al., 2013 http://methylcrf.wustl.edu/
methylMnM Zhang et al., 2013 http://bioconductor.org/packages/
release/bioc/html/methylMnM.html
Predict cumulative population doublings using DNA
methylation of 6 CpG sites
Koch and Wagner, 2013 Figure 6 and Table S7
Other
IncuCyte ZOOM System Essen Biosciences N/A
Data visualization in WashU Human Epigenome Browser This paper http://epigenomegateway.wustl.edu/
browser/?genome=hg19&datahub=
http://wangftp.wustl.edu/hlee/EpiX/
EpiX_hg19.json
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METHOD DETAILS
Lentivirus transduction and live-imaging cell growth analysis with IncuCyte
Epithelial cells cultured using the CR method were seeded into 24-well plate and cultured without feeder cells. The cells were
transduced with IncuCyte NucLight Red (nRFP) Lentivirus Reagent (Essen BioScience) and stable clones were established by
puromycin selection. Late-passage nRFP-expressing cells were seeded into collagen-coated 96-well or 384-well plate (Corning).
A collection of small molecules (Tocriscreen Stem Cell Toolbox, Tocris; Table S1) were diluted in culture medium to the desired con-
centrations and added to the culture. The cells were cultured in IncuCyte ZOOM (Essen BioScience) for live-imaging analysis
following the manufacturer’s instructions for 5–7 days. Small molecules with positive effects were purchased individually from
Sigma-Aldrich or Sellekchem for validation. Stocks of the chemicals were prepared by dissolving in DMSO to 10 mM and added
to culture media to desired final concentrations.
Keratinocytes isolation and expansion
Fresh human skin purchased fromZenBio Inc. was cut into small pieces and placed in Dispase solution (Corning) at 4C overnight. The
next day, the epidermis was separated from dermis with forceps and digested in Trypsin-EDTA for 15 minutes. The cell suspension
was filtered through a 40 mm strainer (BD Bioscience) and cultured in EpiX medium.
Cultured cell immunofluorescence
Cells cultured on collagen-coated CultureSlides (Corning) were fixed in 4% PFA for 15 min at room temperature, washed 3 times in
PBST (PBS+0.2% Triton X-100) (5 min/wash) and incubated with the primary antibodies for 2 hours at room temperature or 4C over-
night in PBS + 1% normal goat serum. Following incubation, the cells were rinsed 3 times in PBST and incubated with secondary
antibodies at room temperature for 1–2 hours. After rinsing 3 times in PBST, the nuclei were stained with ProLong Gold with
DAPI (ThermoFisher) and imaged with a fluorescence microscope (EVOS-FL, ThermoFisher).
Telomere length measurement
Genomic DNAwas extracted from the cells using the Quick-DNAMiniprep Plus Kit (Zymo Research) and quantitated on a NanoDrop
2000. Telomere length measurements by quantitative PCR was performed by the Risques Lab at University of Washington.
Quantitative RT-PCR
Total RNA was isolated using the TRIzol Plus RNA Purification Kit (ThermoFisher) and PureLink RNA Mini Kit (ThermoFisher). Total
RNAs from human lung, small intestine and mammary gland were purchased from Clontech and used as control. RT2 Profiler PCR
Array Human Cellular Senescence (QIAGEN) was used to analyze the expression of genes involved in cellular senescence using
twenty nanogram total RNA for each reaction. The primers (forward: 50-TGACACCTCACCTCACCCAC-30; reverse: 50-CACTGTCTTC
CGCAAGTTCAC-30; Taqman probe: 50-ACCCTGGTCCGAGGTGTCCCTGAG-30) were used to determine TERT expression with the
TaqMan RNA-to-CT 1-Step Kit (ThermoFisher), using one hundred nanogram total RNA per reaction.
Karyotype and Whole genome sequencing
Live cells were seeded in flasks and sent to Cell Line Genetics for G-Band Karyotyping service. Genomic DNA was extracted
from the cells using the Quick-DNA Miniprep Plus Kit (Zymo Research) and quantitated on a NanoDrop 2000. Whole genome library
preparation and DNA sequencing on Illumina HiSeq X and data analysis were performed by Novogene Inc.
Differentiation of HBEC at ALI
HBECwere seeded onto polyester Transwell membranes (Corning) at a density of 400,000 cells/cm2 in EpiX+1.5mMCaCl2. After the
cells reached confluence on the insert, the medium was replaced with Pneumacult-ALI medium (STEMCELL Technologies) only in
the lower chamber to initiate air-liquid interface culture. The medium was changed every 2–3 days for 21–28 days until differentiation
was well established. Ciliogenesis was monitored by inverted-phase microscopy. The membranes were fixed in 4% PFA at room
temperature for 10 min, followed by washing and permeabilization in PBST, for immunofluorescence staining. Paraffin section,
H&E and alcian blue staining were performed by VitroVivo Biotech LLC.
Ion channels activity assays
Ussing assays were performed by ChanTest, a subsidiary of Charles River Laboratories. Frozen cells were sent to ChanTest for
plating and differentiation at CRL using the Vertex (Neuberger et al., 2011) or Pneumacult-ALI medium. Short circuit current (ISC)
was evaluated after 32 and 36 days in ALI culture.
Differentiation of keratinocytes at ALI and production of cultured epidermal grafts
HFKwere seeded onto polycarbonate Transwell membranes (Corning) at a density of 400,000 cells/cm2 in EpiX+1.5 mMCaCl2. After
2–3 days, the medium was removed from top chamber and only added in the lower chamber to initiate ALI differentiation. The
medium was changed every 2–3 days for 14 days. To make cultured epidermal graft, HFK were cultured in collage-coated T-75 flask
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in the EpiXmedium until they approached confluence, then themediumwas switched to EpiX+1.5mMCaCl2 and cultured for another
7 days. The whole epidermal sheet was released using Dispase solution at 37C for 30 min.
In vivo tumorigenicity and differentiation
HFK were expanded in EpiX or differentiated for 7 days in EpiX+1.5 mM CaCl2. The cells were harvested with Trypsin-EDTA and
resuspended in HBSS for in vivo tumorigenicity assays in female nude mice, performed by Nobel Life Sciences as contract service
in compliance with established IACUC protocols. Briefly 1.0x107 cells were administered subcutaneously in a volume of 0.1 mL in
Matrigel on the flanks of 6–8 weeks old mice (n = 6 for each group). Following cell injection, body weight and tumor measurements
were recorded twice weekly for 12 weeks. Tissue samples were harvested at specified time points and fixed in formalin for paraffin
sections.
RNA-Seq library preparation
Half million HFK per replicate were collected and stored at 80C in 1 mL of RNAlater solution until use. For late-passage HFK
cultured in KSFM (P5 and P20), 66,000-150,000 cells per replicate were used as the cells quickly ceased expansion in KSFM.
The mRNAwas extracted directly from the cells by using Dynabeads mRNA DIRECT Purification Kit according to the manufacturer’s
instructions. To avoid any genomic DNA and rRNA contamination, eluted mRNA was treated with DNase (TURBO DNA-free Kit) and
bound again to the sameDynabeads used for the original isolation, following themanufacturer’s instructions. RNA-Seq libraries were
generated using ScriptSeq RNA-Seq Library Preparation Kit (Illumina) according to the manufacturer’s instructions.
RNA-Seq data processing
RNA-Seq libraries were sequenced on the Illumina NextSeq 500 platform. The paired-end sequenced reads were aligned to the
reference genome hg19 and transcriptome (gencode v19) using STAR (Dobin et al., 2013) v.2.5.3a with the following
parameters:–outFilterType BySJout–outFilterMultimapNmax 20–outFilterMismatchNmax 999–outFilterMismatchNoverReadLmax
0.04–alignIntronMin 20–alignIntronMax 1000000–alignMatesGapMax 1000000–alignSJoverhangMin 8–alignSJDBoverhangMin 1.
The total number of reads overlapping each gene were counted using featureCounts (Liao et al., 2014) (Subread v.1.5.3) with gen-
code v19 gtf file and the following parameters: -O -s 1–primary -p. Transcripts per million (TPM) were calculated from the read counts
obtained from featureCounts.
Differential gene expression analysis
Differential gene expression was performed by using DESeq2 bioconductor package (Love et al., 2014) v.1.14.1, following standard
workflow suggested by the package. The matrix of genes and read counts generated by featureCounts were used as count matrix
input. The dataset was pre-filtered by removing genes with no or only one count across all samples. For PCA analysis and heatmap,
regularized-logarithm transformation (rlog) was performed for count data to stabilize the variance across the mean. Differentially ex-
pressed genes were identified by comparing two different media conditions, control KSFM (P2, P4, P5, and P20) and EpiX (P3, P12,
and P19). Only genes with log2FC > 1 and adj.p < 0.01 were considered significant. The enrichment of gene ontology terms and path-
ways for DEGs was analyzed by using Metascape (Tripathi et al., 2015).
MeDIP-seq and MRE-seq library preparation
Half million HFK per replicate were collected and stored as a pellet at 80C until use. For late-passage HFK cultured in KSFM
(P5 and P20), 66,000-150,000 cells per replicate were collected due to difficulty of culture expansion. The genomic DNA was
extracted by incubating the cells in genomic DNA extraction buffer (50 mM Tris, 1 mM EDTA, 0.5% SDS, 1 mg/mL Proteinase K)
followed by phenol-chloroform extraction. MeDIP-seq and MRE-seq libraries were generated as described previously (Li et al.,
2015; Maunakea et al., 2010), with minor modifications. For MeDIP-seq, 100 ng of genomic DNA was sonicated to a fragment
size of 100-500 bp, end processed and ligated to paired-end adapters. The DNA was then denatured and immunoprecipitated using
100 ng ofmousemonoclonal anti-methylcytidine antibody in 400 mL of immunoprecipitation buffer (10 mMsodium phosphate, pH 7.0,
140 mM NaCl and 0.05% Triton X-100) overnight at 4C. Antibody/DNA complexes were isolated by addition of 0.1 mL of rabbit anti-
mouse IgG secondary antibody (2.0mg/mL, Jackson Immunoresearch) and 20 mL protein A/G agarose beads (Pierce Biotechnology)
for 2 h at 4C. Beads were washed ten times with immunoprecipitation buffer and then DNA was eluted in TE buffer with 0.25% SDS
and 0.25 mg/mL of proteinase K for 2 h at 50C. DNA was then purified with MinElute PCR Purification kit (QIAGEN). DNA was
amplified by 17 cycles of PCR with the standard Illumina index primers and size selected (150–500 bp) by Agencourt AMPure XP
beads (Beckman Coulter). For MRE-seq, five parallel digests (HpaII, Hin6I, SsiI, BstUI and HpyCH4IV; New England Biolabs) were
performed, each with 20 ng of genomic DNA. The digested DNA was size selected using Agencourt AMPure XP beads (Beckman
Coulter), end processed and ligated to adapters. Then DNA was amplified by 18 cycles of PCR and size selected (150–500 bp) by
Agencourt AMPure XP beads (Beckman Coulter).
DNA methylome data processing
MeDIP-seq and MRE-seq libraries were sequenced on the Illumina NextSeq 500 platform. The sequenced reads were adaptor-
trimmed by using cutadapt (Martin, 2011) v.1.9 paired-end mode with the parameters -q 10 -m 20. Trimmed reads were aligned
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to the hg19 genome assembly using BWA-MEM (Li, 2013) v.0.7.10 with the default parameters. The aligned MeDIP-seq reads were
further processed using methylQA (Li et al., 2015) v.0.1.6 medip mode with the default parameters. The alignedMRE-seq reads were
processed using methylQA (Li et al., 2015) v.0.1.6 mre mode with the parameter -c 4. Methylation levels at single CpG resolution
were estimated by integrating MeDIP-seq and MRE-seq data using methylCRF with default parameters as described previously
(Stevens et al., 2013).
Identification of differentially methylated regions
Differentially methylated regions between two culture conditions were identified by using methylMnM package (Zhang et al., 2013)
with the default parameters. Briefly, the coverage of MeDIP and MRE sequencing data and genomic CpG information were calcu-
lated in each 500-bp genomic bin. The CpGs in the human blacklisted genomic regions (ENCODE Project Consortium, 2012) and
the mitochondrial genome were excluded from the analysis. DMRs with a q-value (false discovery rate) < 1 3 105 were selected
for each pairwise comparison (Figure S10A). Highly reproducible set of DMRs were identified by intersecting all four pairwise com-
parisons between two different conditions with two biological replicates and were used for further analysis (Figure 6B).
DNA Methylation analyses
Average DNA methylation level of each DMR was calculated by using CpG methylation levels estimated by methylCRF. Principal
component analysis was performed on the average DNA methylation levels of all union set of 2,419 DMRs with high reproducibility.
The chromatin states of each DMR was determined by intersecting either core 15 chromHMM states or expanded 18 states of fetal
keratinocytes (ID# 057 and 058) from Roadmap Epigenomics Consortium data.
Prediction of cumulative population doublings
To predict cPDs, genomic coordinates of 6 CpG sites were determined by using sequences surrounding the CpG sites.
For cg03891191, two genomic locations were found in hg19 genome assembly and average of methylCRF values of two
locations were used. Cumulative population doublings were calculated by using the following equation (Koch and Wagner, 2013):
pcPD = 45.89 + (23.63 3 cg02332525) + (31.61 3 cg17453778) + (53.70 3 cg03891191) + (14.86 3 cg01459453) + (23.94 3
cg01999333) + (10.34 3 cg16431978).
QUANTIFICATION AND STATISTICAL ANALYSIS
IncuCyte Zoomwas used for live imaging and automatic cell counts in 96-well or 384-well plates. Automatic cell count was facilitated
by counting nuclear-localized RFP. For multi-well plate assay, each condition had 3–4 replicates, and all error bars correspond to SD.
GraphPad Prism 7.0 was used for non-parametric tests. Unpaired data was compared using Kruskal-Wallis test. Differences were
considered significant if p < 0.05. All collected data were included for the quantification and the statistical analysis.
In the transcriptome study, regularized-logarithm transformation (rlog) was performed for count data to stabilize the variance
across the mean for PCA analysis and heatmap. Differentially expressed genes were identified by comparing two different media
conditions, and only genes with log2FC > 1 and adj.p < 0.01 were considered significant. In the DNA methylation study, DMRs
with a q-value (false discovery rate) < 1 3 105 were selected for each pairwise comparison (Figure S10A). Highly reproducible
set of DMRs were identified by intersecting all four pairwise comparisons between two different conditions with two biological rep-
licates and were used for further analysis (Figure 6B).
DATA AND SOFTWARE AVAILABILITY
The accession number for the data reported in this paper is Gene Expression Omnibus (GEO): GSE103759, and contains the
subseries GEO: GSE103756 (RNA-seq), GSE103757 (MeDIP-seq), and GSE103758 (MRE-seq). All data generated in this study
have been visualized in WashU Human Epigenome Browser (Zhou et al., 2011) and is publicly available in the following url: http://
epigenomegateway.wustl.edu/browser/?genome=hg19&datahub=http://wangftp.wustl.edu/hlee/EpiX/EpiX_hg19.json.
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Figure S1: TGF-β and ROCK inhibition extended the proliferation of epithelial cells in the F medium. Related to 
Figure 1. A-B. Proliferation of PrEC/nRFP cells in the F medium supplemented with each small molecule at 0.2 µM 
or 5 µM in the absence of feeder cells (data are represented as mean ± SD, n=3). C. Proliferation of PrEC/nRFP 
cells in the F medium supplemented with 5 µM Y-27632 and each small molecule at 1 µM (data are represented as 
mean ± SD, n=3). D. Population doublings (PDs) of naïve PrEC in PrGM (Lonza), F+Y (F medium supplemented 
  
with 5 µM Y-27632) and F+Y+A (F medium supplemented with 5 µM Y-27632 and 1 µM A83-01) in the absence 
of feeder cells. E. Prostate epithelial cells in F+Y+A (passage 8), most of the cells exhibited differentiated 
morphology.  
  
 
Figure S2: TGF-β and PAK1-ROCK-Myosin II inhibition extended the proliferation of epithelial cells in KSFM. 
Related to Figure 1. A. Proliferation of late-passage PrEC/nRFP cells in KSFM supplemented with 1 µM A83-01 
and each small molecule at 0.2 µM, 1 µM or 5 µM (dose escalation from left to right, data are represented as mean ± 
SD, n=3). B. Proliferation of late-passage HBEC/nRFP cells in KSFM supplemented with 1 µM A83-01 and 5 µM 
Y-27632 and each small molecule at 0.2 µM, 1 µM or 5 µM (dose escalation from left to right, data are represented 
as mean ± SD, n=3). C-D. Titration of A83-01 and IPA-3 on the growth of PrEC/nRFP or HBEC/nRFP cells in 
  
KSFM (average of 4 replicates). E-F. Population doublings of PrEC or HBEC in PrGM (Lonza); KSFM; KSFM 
supplemented with 5 µM Y-27632 (KSFM+Y); KSFM supplemented with 1 µM A83-01 (KSFM+A); KSFM 
supplemented with 5 µM Y-27632 and 1 µM A83-01 on regular tissue culture vessel (KSFM+A+Y); or KSFM 
supplemented with 5 µM Y-27632 and 1 µM A83-01 on collagen I coated culture vessel (KSFM+A+Y(collagen)). 
G-J. Population doublings of naïve bronchial epithelial cells, prostate epithelial cells, foreskin keratinocytes and 
adult keratinocytes in different conditions. KSFM; K+Y+A, KSFM with 1 µM A83-01 and 5 µM Y-27632; 
K+A+IPA, KSFM with 1 µM A83-01 and 0.2 µM IPA-3; K+A+B, KSFM with 1 µM A83-01 and 2 µM 
blebbistatin; CR, conditional reprogramming method.  
  
 
Figure S3: Nuclear translocation of YAP and reduced TGF-β protein expression by the epithelial cells cultured in 
the EpiX medium. Related to Figure 1. A. Interaction between A83-01 and CaCl2 on the proliferation of HFK cells 
in KSFM (average of 4 replicates). B. Interaction between Y-27632 and CaCl2 on the proliferation of HFK cells in 
KSFM (average of 4 replicates). Elevated CaCl2 concentration decreased the proliferation-promoting effect of A83-
  
01 but boosted the effect of Y-27632. C, D. Immunofluorescence staining of YAP using an antibody and actin 
cytoskeleton using Phalloidin in HFK cultured in KSFM (90 µM CaCl2) or KSFM plus 1.5 mM CaCl2. E-F. Active 
TGF-β expressed by HFK or PrEC cells cultured in KSFM, KSFM with 5 µM Y-27632 (KSFM+Y), KSFM with 1 
µM A83-01 (KSFM+A), EpiX (KSFM + 1 µM A83-01 + 5 µM Y-27632 + 3 µM Isoproterenol), or KSFM with 1.5 
mM CaCl2. TGF-β was expressed by HFK and PrEC in KSFM, and the TGF-β protein level was greatly reduced in 
the EpiX medium (ELISA assay data are represented as mean ± SD, n=3 replicates) .  
  
 
Figure S4: Propagation of primary epithelial cells from various tissues in the EpiX medium. Related to Figure 1. A. 
Various epithelial cells generally reach <20 PDs in the media recommended by the suppliers. The same cells could 
be expanded for more than 40 PDs in the EpiX medium. *, keratinocytes isolated in the EpiX medium reached more 
PDs than the ones purchased from commercial source. The cells are obtained from ThermoFisher (HFKn and HEKa) 
or Lonza (HMEC, PrEC, HBEC and DHBE-CF). HFKn, neonatal human foreskin keratinocyte. HEKa, adult human 
  
epidermal keratinocyte. HMEC, human mammary epithelial cells (female). PrEC, human prostate epithelial cells. 
HBEC, human bronchial epithelial cells. DHBE-CF, diseased human bronchial epithelial cells from a cystic fibrosis 
patient. KSFM, Keratinocyte-SFM (ThermoFisher). PrGM, Prostate Epithelial Cell Growth Medium (Lonza). A, 
ALK5 inhibitor A83-01. Y, ROCK inhibitor Y-27632. B, Myosin II inhibitor blebbistatin. IPA, PAK1 inhibitor 
IPA-3. GSK, ROCK inhibitor GSK-429286. B. Expansion of primary nasal epithelial cells from nasal brushing 
samples obtained from 7 CF patients (all have homozygous ∆F508 mutations). More than 50 million nasal epithelial 
cells can be generated in 3–4 weeks. C. Nasal brushing samples collected from a CF patient. D. Expansion curves of 
7 CF nasal epithelial cell strains in the EpiX medium over 5 weeks.   
  
 
Figure S5: EpiX medium supported single cell cloning and genetic engineering by CRISRP/Cas9. Related to Figure 
1. A. B. Limited dilution of HFK/nRFP and HBEC/nRFP cell lines in 384-well plate. One cell grew up into a colony 
in about 2 weeks. C. Single cell cloning efficiency of HFK/nRFP and HBEC/nRFP cell lines in the EpiX medium. 
The number of cells in each colony were counted after 10 days. D. PrEC, HBEC and HFK were engineered to 
  
express nRFP via lentivirus transduction and continued to expand for more than 30 PDs in the EpiX medium. E. 
Introducing a GFP-expression cassette into the AAVS1 locus of HFK by CRISRP/Cas9 RNP. Primers used to 
confirm the targeting events were depicted. Genomic DNA PCR were used to confirm the correct targeting of GFP-
expression cassette into the AAVS1 locus. Both AAVS1 loci were targeted in Clone 3E6, and one locus was 
targeted in clones 6B3 and 4H11. F. Morphology of HFK expressing GFP from the AAVS1 locus (clone 6B3) under 
phase contrast and fluorescence microscopy.  
  
  
 
Figure S6: Transcriptome dynamics of epithelial cells expanded in the EpiX medium. Related to Figure 2. A. B. 
qRT-PCR analysis of TERT expression in human prostate epithelial cells and bronchial epithelial cells cultured 
under different conditions. Prostate cancer cell line LNCaP was used as control for the expression of TERT, which 
was set as 1. n.d. not detected. C. qRT-PCR analysis of several stressed-related genes expression in HFK cultured in 
the EpiX medium or KSFM. The gene expression level was expressed as relative to that of β-actin, which was set as 
  
1. D. Recapitulation of qRT² Profiler PCR Array results by RNA-Seq data. Each dot represented the expression of a 
gene in one matched condition. Each gene had five matched conditions: P2 in KSFM, P5 or P6 in KSFM, P2 or P3 
in EpiX, P12 or P13 in EpiX, and P19 or P23 in EpiX. X-axis represented qRT-PCR expression value relative to the 
housekeeping gene β-actin expression level, which could be found in Table S2. Y-axis represented TPM value from 
RNA-Seq, which could be found in Table S2. Pseudocount 10-5 was added to each value and log-transformed. 
Pearson correlation coefficient was calculated and shown with p-value. E. Gradual changes of gene expression in 
the increasing passages in the EpiX medium. The expression levels of differentially expressed genes in P12 passage 
was intermediate between P3 and P19 passages. Y-axis represented rlog-transformed read counts. F. The heatmap of 
the expression levels of differentially expressed genes over increased passages in EpiX medium and gene ontology 
and pathway enrichment analysis of downregulated and upregulated genes by metascape tool. G. Heatmap of the 
expression levels of genes in KEGG human TGF-β signaling pathway among different culture conditions.  
  
Figure S7: Locations of copy number variations (CNV) that were identified the CF sample by whole genome 
sequencing. Related to Figure 3 and Table S4. Blue triangles indicated the locations of losses in CNV, and red 
triangles indict the locations of gains in CNV.  
  
 
Figure S8: in vivo luminescence imaging of HFK expressing firefly luciferase (HFK/Luc) that were injected 
subcutaneously into NSG mice. Related to Figure 4. Luminescence signal was readily detected 122 days after the 
HFK cells were injected into the NSG mouse, suggesting that EpiX-expanded HFK retained self-renewal ability in 
vivo.   
  
Figure S9: Heat-map of gene expressions associated with cellular senescence (genes included in the RT2 Profiler™ 
PCR Array). Related to Figures 2 and 6.   
  
 
Figure S10: DNA methylation changes of HFK expanded in the EpiX medium. Related to Figure 6. A. The average 
DNA methylation levels of all CpGs estimated by methylCRF (line plot) and the percentage of CpGs with high, 
medium, and low methylation levels (bar plot). B. The methylation level distribution of all CpGs. The CpG 
methylation levels showed bimodal distribution with two peaks of low (0-10%) and high (80-100%) methylation 
levels. C. The average DNA methylation levels over genic and 2kb neighboring regions. TTS, transcription start 
site. TES, transcription end site. D. Number of DMRs identified in all pair-wise comparisons. E. The heatmap of 
  
DNA methylation levels of all 2419 DMRs across passages. F. The chromatin states of DMRs using chromHMM 15 
core states in two keratinocytes (E057 and E058). G. The epigenome browser view of DMRs located on the 
promoter of the gene CASP8. The gene expression level was downregulated as the promoter gained DNA 
methylation level across passages. H. The heatmap of expression levels of genes with promoter methylation 
changes. Gene expression levels were considered as not detected (grey, TPM < 0.5), low (light blue, TPM of 0.5 to 
10), medium (blue, TPM of 10 to 1000), or high (dark blue, TPM ≥ 1000) according to its TPM value. I. The 
heatmap of DNA methylation levels of promoters and its 5kb-neighboring regions of various pathway related genes. 
TSS, transcription start site.  
  
Table S7: Prediction of cumulative population doublings. Related to Figure 6. 
CpG site 1 2 3 3 4 5 6 Actual 
cPDs 
Predicted 
cPDs 
ID cg02332525 cg17453778 cg03891191 cg03891191 cg01459453 cg01999333 cg16431978 
Associated 
gene 
GRM7 CASR PRAMEF2 PRAMEF13 SELP CASP14 KRTAP13-3 
hg19 
coordinates 
chr3:69031
52-6903154 
chr3:121902
560-
121902562 
chr1:129169
97-
12916999 
chr1:134525
81-
13452583 
chr1:169599
211-
169599213 
chr19:15162
622-
15162624 
chr21:31797
931-
31797933 
p02_KSFM
_rep1 
0.04 0.05 0.86 0.32 0.90 0.90 0.83 7.5 0.0 
p02_KSFM
_rep2 
0.04 0.04 0.90 0.32 0.90 0.90 0.79 -1.0 
p05_KSFM
_rep1 
0.04 0.04 0.84 0.32 0.90 0.84 0.83 17.6 1.6 
p05_KSFM
_rep2 
0.04 0.04 0.86 0.32 0.90 0.77 0.83 2.8 
p03_EpiX_
rep1 
0.04 0.04 0.86 0.32 0.87 0.85 0.83 14.2 0.4 
p03_EpiX_
rep2 
0.04 0.04 0.86 0.32 0.87 0.84 0.83 0.7 
p12_EpiX_
rep1 
0.04 0.04 0.86 0.32 0.85 0.84 0.79 45.7 0.8 
p12_EpiX_
rep2 
0.04 0.04 0.86 0.32 0.90 0.44 0.83 10.7 
p19_EpiX_
rep1 
0.04 0.04 0.87 0.32 0.88 0.08 0.46 73.0 22.6 
p19_EpiX_
rep2 
0.04 0.04 0.84 0.32 0.88 0.08 0.43 23.7 
p04_KSFM
_rep1 
0.04 0.04 0.90 0.32 0.88 0.49 0.85 15.6 7.9 
p04_KSFM
_rep2 
0.04 0.04 0.86 0.32 0.88 0.08 0.83 19.0 
p20_KSFM
_rep1 
0.04 0.05 0.86 0.32 0.88 0.08 0.46 71.3 23.1 
p20_KSFM
_rep2 
0.04 0.04 0.84 0.32 0.88 0.08 0.83 19.5 
E057_meth
ylCRF 
0.04 0.04 0.91 0.33 0.90 0.90 0.92   -2.9 
E058_meth
ylCRF 
0.04 0.04 0.60 0.33 0.90 0.90 0.92   5.4 
E058_WG
BS 
0.00 0.00 0.43 ND 0.87 1.00 0.95   2.0 
 
